Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)
Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%
Zoetis price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Zoetis's price to sales ratio was 3.6× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 3.0× to 15.2×, with a median of 8.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.6× | −2.3 |
| 2025 | Dec 31, 2025 | 5.9× | −2.1 |
| 2024 | Dec 31, 2024 | 8.0× | −2.8 |
| 2023 | Dec 29, 2023 | 10.8× | +2.3 |
| 2022 | Dec 30, 2022 | 8.5× | −6.6 |
| 2021 | Dec 31, 2021 | 15.2× | +3.1 |
| 2020 | Dec 31, 2020 | 12.0× | +1.8 |
| 2019 | Dec 31, 2019 | 10.3× | +3.1 |
| 2018 | Dec 31, 2018 | 7.2× | +0.3 |
| 2017 | Dec 29, 2017 | 6.9× | +1.4 |
| 2016 | Dec 30, 2016 | 5.4× | +0.5 |
| 2015 | Dec 31, 2015 | 5.0× | +0.4 |
| 2014 | Dec 31, 2014 | 4.6× | +0.9 |
| 2013 | Dec 31, 2013 | 3.6× | – |
See a number that looks wrong?